North Alabama Neuroscience Research Associates

Huntsville, Alabama 35801

0 studies enrolling now · 5 studies all time

What they study most

Epilepsy, Neuralgia, Parkinson's Disease, Peripheral Nervous System Disease, Refractory Partial Seizures, Seizures, Shingles

Studies at this site

• Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial — Completed
• Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy — Completed
• To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures — Completed
• Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations — Completed
• Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia — Status unconfirmed